Sernova Biotherapeutics Inc. (TSX: SVA, OTC: SEOVF) and Seraxis Holdings, Inc. have closed a US$11.2 million non-brokered convertible note financing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA